Artal Group S.A. - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 59 filers reported holding PROQR THRAPEUTICS N V in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q4 2020$5,024,000
-12.3%
1,196,2180.0%0.11%
-22.3%
Q3 2020$5,730,000
-25.2%
1,196,218
-5.0%
0.14%
-35.0%
Q2 2020$7,656,000
+7.3%
1,259,177
-3.1%
0.21%
-29.1%
Q1 2020$7,137,000
-44.6%
1,300,0000.0%0.30%
-39.4%
Q4 2019$12,883,000
+72.0%
1,300,0000.0%0.50%
+66.0%
Q3 2019$7,488,000
-36.7%
1,300,0000.0%0.30%
-37.2%
Q2 2019$11,830,000
-39.1%
1,300,000
-7.1%
0.48%
-39.7%
Q1 2019$19,418,000
-12.1%
1,400,0000.0%0.79%
-3.1%
Q4 2018$22,092,000
-12.2%
1,400,000
+7.7%
0.82%
+25.1%
Q3 2018$25,155,000
+129.7%
1,300,000
-13.3%
0.65%
+180.7%
Q2 2018$10,950,000
+87.4%
1,500,000
-21.1%
0.23%
+219.2%
Q1 2018$5,843,000
-4.7%
1,900,0000.0%0.07%
-20.7%
Q4 2017$6,128,000
-15.8%
1,900,000
+26.7%
0.09%
-26.4%
Q3 2017$7,275,000
+179.8%
1,500,000
+200.0%
0.12%
+177.8%
Q2 2017$2,600,000
+30.0%
500,000
+25.0%
0.04%
+2.3%
Q1 2017$2,000,000400,0000.04%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q4 2018
NameSharesValueWeighting ↓
Privium Fund Management B.V. 5,344,446$18,010,7836.83%
M28 Capital Management LP 1,910,600$7,069,2206.74%
Opaleye Management Inc. 1,460,000$5,402,0001.88%
Ikarian Capital, LLC 422,625$1,563,7130.38%
Monaco Asset Management SAM 165,000$610,5000.18%
AWM Investment Company, Inc. 166,667$616,6680.09%
FRANKLIN STREET ADVISORS INC /NC 150,000$5550.05%
Atom Investors LP 18,522$68,5310.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$13,414,2280.03%
GSA CAPITAL PARTNERS LLP 21,514$800.01%
View complete list of PROQR THRAPEUTICS N V shareholders